Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo aims to keep ovarian cancer at bay

NCT ID NCT07318558

Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 19 times

Summary

This Phase 3 trial tests whether a targeted therapy called sacituzumab tirumotecan (Sac-TMT), given alone or with bevacizumab, can help people with advanced ovarian cancer live longer without their cancer growing. About 900 participants who have finished initial chemotherapy will receive either the study drug(s) or standard care. The goal is to find a better maintenance treatment option.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sacituzumab tirumotecan (Sac-TMT) and bevacizumab
What this could lead to
If successful, this could offer a new maintenance option to help people with advanced ovarian cancer live longer without their cancer worsening.
What could go wrong
This is a large Phase 3 trial, but it is still experimental. The drug may not improve outcomes over standard care, and side effects like infusion reactions or mouth sores are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 900 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2033

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The main inclusion criteria include but are not limited to the following: * Has diagnosis of FIGO 2014 Stage III or Stage IV, histologically confirmed epithelial ovarian, primary peritoneal, or fallopian tube carcinoma with one of the following histologies: high-grade serous, high-grade endometrioid, clear cell carcinoma, or malignant mixed Müllerian tumour with a high-grade serous component. Tumors reported as Grade 2 may be enrolled only if predominately (\>50%) Grade 3 features are present. * Has completed primary debulking surgery or interval debulking surgery. * Has completed first-line (1L) platinum-based chemotherapy, with a response of stable disease, partial response, complete response or no evidence of disease per protocol. * Has provided tumor tissue that is not previously irradiated. * Has well-controlled human immunodeficiency virus (HIV) on antiretroviral therapy if diagnosed with HIV * Has undetectable hepatitis B virus (HBV) viral load and received HBV antiviral therapy if hepatitis B surface antigen (HBsAg)-positive. * Has undetectable hepatitis C virus (HCV) viral load if has a history of HCV infection. The main exclusion criteria include but are not limited to the following: * Has nonepithelial cancers, low-grade serous tumors, low-grade endometrioid tumors, borderline tumors mucinous, seromucinous that is predominantly mucinous, malignant Brenner's tumor, and undifferentiated carcinoma. * Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis. * Has a history of severe eye disease. * Has active inflammatory bowel disease requiring immunosuppressive medication or a previous history of inflammatory bowel disease. * Has uncontrolled, significant cardiovascular disease or cerebrovascular disease. * Has a history of (noninfectious) pneumonitis/interstitial lung disease (ILD), which required steroids, has current pneumonitis/ILD, or has suspected ILD, or pneumonitis that cannot be ruled out by standard diagnostic assessments at Screening. * Received prior systemic anticancer therapy, with the exception of the first-line platinum-based chemotherapy required by the inclusion criteria. * Had a live or live-attenuated vaccine within 30 days of randomization. * Has a known additional malignancy that is progressing or required active treatment within the past 3 years. * Has active infection requiring systemic therapy. * Has concurrent and active HBV and HCV infections. * Has HIV infection and a history of Kaposi's sarcoma and/or multicentric Castleman's disease. * Has not recovered from major surgery or has ongoing surgical complications. * Has a homologous recombination deficiency (HRD)-positive, unknown, or inconclusive tumor status as determined by the central laboratory. * Active or ongoing stomatitis of any grade.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epithelial ovarian cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fallopian tube carcinoma ovarian cancer ovarian carcinoma ovarian neoplasm primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ovarian cancer Ovarian neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    163 sites in 29 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • ANIMI - Unidade de Tratamento Oncologico ( Site 0421)

    RECRUITING

    Lages, Santa Catarina, 88501-001, Brazil

  • ASST DI LECCO ( Site 1509)

    RECRUITING

    Lecco, 23900, Italy

  • AZ Maria Middelares ( Site 0302)

    RECRUITING

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • Aalborg Universitetshospital ( Site 0901)

    RECRUITING

    Aalborg, North Denmark, 9000, Denmark

  • Aarhus Universitetshospital, Skejby ( Site 0903)

    RECRUITING

    Aarhus, North Denmark, 8200, Denmark

  • Addenbrookes Hospital ( Site 2802)

    RECRUITING

    Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom

  • Agios Loukas Clinic ( Site 0702)

    RECRUITING

    Thessaloniki, 552 36, Greece

  • Aichi Cancer Center ( Site 1601)

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Alexandra General Hospital of Athens ( Site 0703)

    RECRUITING

    Athens, Attica, 115 28, Greece

  • Asan Medical Center ( Site 2305)

    RECRUITING

    Seoul, 05505, South Korea

  • Azienda Ospedaliera Spedali Civili di Brescia ( Site 1501)

    RECRUITING

    Brescia, 25123, Italy

  • Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 3910)

    RECRUITING

    Kecskemét, Bács-Kiskun county, 6000, Hungary

  • Bialostockie Centrum Onkologii ( Site 2104)

    RECRUITING

    Bialystok, Podlaskie Voivodeship, 15-027, Poland

  • CENTRE LEON BERARD ( Site 1101)

    RECRUITING

    Lyon, Auvergne-Rhône-Alpes, 69008, France

  • CHRU de Brest - Hopital de la Cavale Blanche ( Site 1104)

    RECRUITING

    Brest, Finistere, 29200, France

  • CIUSSS - Saguenay-Lac-Saint-Jean ( Site 0519)

    RECRUITING

    Chicoutimi, Quebec, G7H 5H6, Canada

  • Cancer Institute Hospital of JFCR ( Site 1614)

    RECRUITING

    Koto, Tokyo, 135-8550, Japan

  • Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau ( Site 1105)

    RECRUITING

    Tours, Indre-et-Loire, 37044, France

  • Centre Hospitalier Universitaire Dupuytren ( Site 1112)

    RECRUITING

    Limoges, Haute-Vienne, 87042, France

  • Centre Hospitalier de l'Université de Montréal ( Site 0518)

    RECRUITING

    Montreal, Quebec, H2X 3H8, Canada

  • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 1113)

    RECRUITING

    Clermont-Ferrand, Puy-de-Dome, 63003, France

  • Centre Oscar Lambret ( Site 1106)

    RECRUITING

    Lille, Nord, 59020, France

  • Clinica Puerto Montt ( Site 0606)

    RECRUITING

    Port Montt, Los Lagos Region, 5507642, Chile

  • Clinica Universidad de Navarra ( Site 2407)

    RECRUITING

    Madrid, Madrid, Comunidad de, 28027, Spain

  • Clínica Alemana de Santiago ( Site 0610)

    RECRUITING

    Santiago, Region M. de Santiago, 7650568, Chile

  • Clínica San Felipe ( Site 3603)

    RECRUITING

    Lima, 15072, Peru

  • Complejo Hospitalario Universitario A Coruna ( Site 2412)

    RECRUITING

    A Coruña, La Coruna, 15006, Spain

  • Cork University Hospital ( Site 1303)

    RECRUITING

    Cork, T12 DC4A, Ireland

  • Debreceni Egyetem Klinikai Kozpont-Szülészeti és Nőgyógyászati Klinika ( Site 3912)

    RECRUITING

    Debrecen, 4032, Hungary

  • Duke Cancer Center ( Site 0012)

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Edith Wolfson Medical Center ( Site 1423)

    RECRUITING

    Holon, 5810001, Israel

  • Epworth Freemasons ( Site 0207)

    RECRUITING

    East Melbourne, Victoria, 3002, Australia

  • Evgenidion Clinic Agia Trias S.A ( Site 0701)

    RECRUITING

    Athens, Attica, 115 28, Greece

  • FALP ( Site 0607)

    RECRUITING

    Santiago, Region M. de Santiago, 7500921, Chile

  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0801)

    RECRUITING

    Bogotá, Bogota D.C., 110131, Colombia

  • Faculty of Medicine - Khon Kaen University ( Site 3403)

    RECRUITING

    Muang, Changwat Khon Kaen, 40002, Thailand

  • Faculty of Medicine Siriraj Hospital ( Site 3401)

    RECRUITING

    Bangkoknoi, Bangkok, 10700, Thailand

  • Fakultni Nemocnice Brno Bohunice ( Site 3304)

    RECRUITING

    Brno, Brno-mesto, 602 00, Czechia

  • Fakultni nemocnice Hradec Kralove ( Site 3307)

    RECRUITING

    Hradec Králové, 500 05, Czechia

  • Fakultni nemocnice Kralovske Vinohrady ( Site 3306)

    RECRUITING

    Prague, 100 34, Czechia

  • Fakultni nemocnice Ostrava-Gynekologicko-porodnicka klinika ( Site 3303)

    RECRUITING

    Ostrava-Poruba, Ostrava Mesto, 708 52, Czechia

  • Fakultni nemocnice motol ( Site 3302)

    RECRUITING

    Prague, 150 06, Czechia

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1510)

    RECRUITING

    Roma, 00168, Italy

  • Franciscan Health Indianapolis ( Site 0081)

    RECRUITING

    Indianapolis, Indiana, 46237, United States

  • Fundacion Colombiana de Cancerología Clinica Vida ( Site 0803)

    RECRUITING

    Medellín, Antioquia, 050030, Colombia

  • Fundación CORI para la Investigación y Prevención del Cáncer ( Site 2907)

    RECRUITING

    La Rioja, F5300COE, Argentina

  • Fundación Respirar ( Site 2912)

    RECRUITING

    Buenos Aires, Buenos Aires F.D., C1426AAL, Argentina

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0414)

    RECRUITING

    São José do Rio Preto, São Paulo, 15090-000, Brazil

  • Gallipoli Medical Research Ltd ( Site 0204)

    RECRUITING

    Brisbane, Queensland, 4120, Australia

  • Grand Hopital de Charleroi ( Site 0303)

    RECRUITING

    Charleroi, Hainaut, 6000, Belgium

  • Gunma Prefectural Cancer Center ( Site 1605)

    RECRUITING

    Ōta, Gunma, 373-8550, Japan

  • Henry-Joyce Cancer Clinic ( Site 0011)

    RECRUITING

    Nashville, Tennessee, 37232, United States

  • Herlev Hospital ( Site 0902)

    RECRUITING

    Herlev, Capital Region, 2730, Denmark

  • Hokkaido University Hospital ( Site 1609)

    RECRUITING

    Sapporo, Hokkaido, 060-8648, Japan

  • Hopitaux Universitaires de Strasbourg ( Site 1109)

    RECRUITING

    Strasbourg, Bas-Rhin, 67000, France

  • Hospital Aleman ( Site 2903)

    RECRUITING

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1119ACN, Argentina

  • Hospital Britanico de Buenos Aires ( Site 2905)

    RECRUITING

    CABA, C1280AEB, Argentina

  • Hospital Clinic I Provincial de Barcelona ( Site 2409)

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital Clinico San Carlos... ( Site 2410)

    RECRUITING

    Madrid, 28040, Spain

  • Hospital Ramon y Cajal ( Site 2405)

    RECRUITING

    Madrid, 28034, Spain

  • Hospital São Lucas da PUCRS ( Site 0415)

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90610000, Brazil

  • Hospital Universitario La Paz-Oncología Médica ( Site 2404)

    RECRUITING

    Madrid, 28046, Spain

  • Hospital Universitario Reina Sofia ( Site 2406)

    RECRUITING

    Córdoba, 14004, Spain

  • Hospital Vall D Hebron ( Site 2403)

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital of the University of Pennsylvania ( Site 0071)

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Hyogo Cancer Center ( Site 1620)

    RECRUITING

    Akashi, Hyōgo, 673-8558, Japan

  • Hôpital Privé Des Côtes d'Armor ( Site 1102)

    RECRUITING

    Plérin, Cotes-d Armor, 22190, France

  • Hôpitaux Universitaires de Genève (HUG) ( Site 3502)

    RECRUITING

    Geneva, 1205, Switzerland

  • IBCC - Núcleo de Pesquisa e Ensino ( Site 0416)

    RECRUITING

    São Paulo, 04014-002, Brazil

  • ICO L Hospitalet ( Site 2408)

    RECRUITING

    Barcelona, 08907, Spain

  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 3604)

    RECRUITING

    Lima, 15036, Peru

  • Illinois Cancer Specialists (ICS) ( Site 8009)

    RECRUITING

    Arlington Heights, Illinois, 60005, United States

  • Inselspital Bern ( Site 3504)

    RECRUITING

    Bern, Canton of Bern, 3010, Switzerland

  • Institut Català d'Oncologia (ICO) - Girona ( Site 2402)

    RECRUITING

    Girona, Gerona, 17007, Spain

  • Institut Paoli Calmettes ( Site 1111)

    RECRUITING

    Marseille, Bouches-du-Rhone, 13273, France

  • Instituto Alexander Fleming ( Site 2902)

    RECRUITING

    Ciudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ, Argentina

  • Instituto Nacional De Cancerologia ( Site 0808)

    RECRUITING

    Bogota, Cundinamarca, 111151, Colombia

  • Instituto Valenciano de Oncologia - IVO ( Site 2411)

    RECRUITING

    Valencia, Valenciana, Comunitat, 46009, Spain

  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 2901)

    RECRUITING

    Mar del Plata, Buenos Aires, B7600FZO, Argentina

  • Instituto de Oncologia de Rosario ( Site 2909)

    RECRUITING

    Rosario, Santa Fe Province, S2000KZE, Argentina

  • Istituto Europeo di Oncologia ( Site 1503)

    RECRUITING

    Milan, 20141, Italy

  • Istituto Nazionale dei Tumori ( Site 1504)

    RECRUITING

    Milan, 20133, Italy

  • Istituto Oncologico Veneto ( Site 1506)

    RECRUITING

    Padova, 35128, Italy

  • Iwate Medical University Hospital ( Site 1610)

    RECRUITING

    Shiwa-gun, Iwate, 028-3695, Japan

  • John Muir Health Cancer Center ( Site 0069)

    RECRUITING

    Walnut Creek, California, 94598, United States

  • Kagoshima City Hospital ( Site 1613)

    RECRUITING

    Kagoshima, 890-8760, Japan

  • Kantonsspital Graubünden ( Site 3503)

    RECRUITING

    Chur, Kanton Graubünden, 7000, Switzerland

  • Karolinska Universitetssjukhuset Solna ( Site 2502)

    RECRUITING

    Stockholm, Stockholm County, 171 76, Sweden

  • Keimyung University Dongsan Hospital ( Site 2304)

    RECRUITING

    Daegu, Taegu-Kwangyokshi, 42601, South Korea

  • Keio University Hospital ( Site 1611)

    RECRUITING

    Shinjyuku, Tokyo, 160-8582, Japan

  • Kuopion Yliopistollinen Sairaala ( Site 1004)

    RECRUITING

    Kuopio, Northern Savonia, 70200, Finland

  • Kurume University Hospital ( Site 1615)

    RECRUITING

    Kurume, Fukuoka, 830-0011, Japan

  • LBM ONCOPOLE CLAUDIUS REGAUD ( Site 1114)

    RECRUITING

    Toulouse, Haute-Garonne, 31059, France

  • Liga Norte Riograndense Contra o Cancer ( Site 0417)

    RECRUITING

    Natal, Rio Grande do Norte, 59062-000, Brazil

  • Linkou Chang Gung Memorial Hospital ( Site 2605)

    RECRUITING

    Taoyuan, 333, Taiwan

  • Mackay Memorial Hospital ( Site 2604)

    RECRUITING

    Taipei, 104, Taiwan

  • Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0060)

    RECRUITING

    Scarborough, Maine, 04074, United States

  • Maryland Oncology Hematology (MOH) ( Site 8002)

    RECRUITING

    Columbia, Maryland, 21044, United States

  • Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2102)

    RECRUITING

    Siedlce, Masovian Voivodeship, 08-110, Poland

  • McGill University Health Centre ( Site 0516)

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Medizinische Universitaet Innsbruck-Univ.-Klinik f. Gynäkologie und Geburtshilfe ( Site 0101)

    RECRUITING

    Innsbruck, Tyrol, 6020, Austria

  • Medizinische Universitat Wien ( Site 0102)

    RECRUITING

    Vienna, State of Vienna, 1090, Austria

  • Memorial Sloan Kettering Cancer Center ( Site 0072)

    RECRUITING

    New York, New York, 10022, United States

  • Mount Sinai Cancer Center ( Site 0029)

    RECRUITING

    Miami Beach, Florida, 33140, United States

  • National Cheng Kung University Hospital ( Site 2602)

    RECRUITING

    Tainan, 704302, Taiwan

  • National Hospital Organization Kyushu Cancer Center ( Site 1603)

    RECRUITING

    Fukuoka, 811-1395, Japan

  • National Taiwan University Hospital ( Site 2601)

    RECRUITING

    Taipei, 10002, Taiwan

  • Nebraska Methodist Hospital ( Site 0004)

    RECRUITING

    Omaha, Nebraska, 68114, United States

  • Niigata Cancer Center Hospital ( Site 1608)

    RECRUITING

    Niigata, 951-8566, Japan

  • ONCOCENTRO APYS-ACEREY ( Site 0603)

    RECRUITING

    Viña del Mar, Valparaiso, 2520598, Chile

  • Obras Sociais Irma Dulce ( Site 0427)

    RECRUITING

    Salvador, Estado de Bahia, 41680-430, Brazil

  • Odense Universitets Hospital ( Site 0904)

    RECRUITING

    Odense, Region Syddanmark, 9000, Denmark

  • Okayama University Hospital ( Site 1619)

    RECRUITING

    Okayama, 700-8558, Japan

  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0007)

    RECRUITING

    Tulsa, Oklahoma, 74146, United States

  • Oncólogos del Occidente S.A.S. ( Site 0806)

    RECRUITING

    Pereira, Risaralda Department, 660001, Colombia

  • Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085)

    RECRUITING

    Orlando, Florida, 32806, United States

  • Országos Onkológiai Intézet-Ngyógyászat ( Site 3913)

    RECRUITING

    Budapest, 1122, Hungary

  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 1604)

    RECRUITING

    Osaka, 541-8567, Japan

  • Oslo University Hospital ( Site 2001)

    RECRUITING

    Oslo, 0424, Norway

  • Ospedale Mauriziano ( Site 1507)

    RECRUITING

    Torino, 10128, Italy

  • Ospedale Regionale Bellinzona e Valli ( Site 3501)

    RECRUITING

    Bellinzona, Canton Ticino, 6500, Switzerland

  • Oulun yliopistollinen sairaala ( Site 1003)

    RECRUITING

    Oulu, North Ostrobothnia, 90220, Finland

  • Parkview Research Center at Parkview Regional Medical Center ( Site 0055)

    RECRUITING

    Fort Wayne, Indiana, 46845, United States

  • Petz Aladar Egyetemi Oktato Korhaz-Onkológiai Osztály ( Site 3911)

    RECRUITING

    Győr, Győr-Moson-Sopron, 9024, Hungary

  • Pontificia Universidad Catolica de Chile ( Site 0602)

    RECRUITING

    Santiago, Region M. de Santiago, 8330073, Chile

  • Ramathibodi Hospital. ( Site 3402)

    RECRUITING

    Bangkok, Bangkok, 10400, Thailand

  • Rambam Health Care Campus ( Site 1422)

    RECRUITING

    Haifa, 3109601, Israel

  • Saitama Medical University International Medical Center ( Site 1607)

    RECRUITING

    Hidaka, Saitama, 350-1298, Japan

  • Samsung Medical Center ( Site 2303)

    RECRUITING

    Seoul, 06351, South Korea

  • Sanatorio Parque - Oncología ( Site 2911)

    RECRUITING

    Rosario, Santa Fe Province, S2000DVC, Argentina

  • Semmelweis Egyetem I. Szamu Szuleszeti es Nogyogyaszati Klinika ( Site 3915)

    RECRUITING

    Budapest, 1088, Hungary

  • Seoul National University Hospital ( Site 2301)

    RECRUITING

    Seoul, 03080, South Korea

  • Severance Hospital ( Site 2302)

    RECRUITING

    Seodaemun-Gu, Seoul, 03722, South Korea

  • Sheba Medical Center ( Site 1421)

    RECRUITING

    Ramat Gan, 5265601, Israel

  • Shizuoka Cancer Center ( Site 1618)

    RECRUITING

    Sunto-gun,, Shizuoka, 411-8777, Japan

  • Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0802)

    RECRUITING

    Valledupar, Cesar Department, 200001, Colombia

  • Sorlandet Sykehus Kristiansand ( Site 2003)

    RECRUITING

    Kristiansand, Vest-Agder, 4615, Norway

  • St James Hospital ( Site 1302)

    RECRUITING

    Dublin, D08 E9P6, Ireland

  • Stavanger Universitetssjukehus ( Site 2002)

    RECRUITING

    Stavanger, Rogaland, 4068, Norway

  • Taichung Veterans General Hospital ( Site 2603)

    RECRUITING

    Taichung, 40705, Taiwan

  • Tampereen yliopistollinen sairaala ( Site 1002)

    RECRUITING

    Tampere, Pirkanmaa, 33520, Finland

  • The Center of Hope ( Site 0025)

    RECRUITING

    Reno, Nevada, 89511, United States

  • The Christie NHS Foundation Trust ( Site 2804)

    RECRUITING

    Manchester, m20 4bx, United Kingdom

  • Turku University Hospital-Department of Obstetrics and Gynecology ( Site 1001)

    RECRUITING

    Turku, Southwest Finland, 20520, Finland

  • UZ Leuven ( Site 0301)

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

  • University College London Hospitals ( Site 2801)

    RECRUITING

    London, London, City of, NW1 2PG, United Kingdom

  • University Hospitals of Leicester NHS Trust ( Site 2805)

    RECRUITING

    Leicester, Leicestershire, LE3 9QP, United Kingdom

  • University Of Nebraska Medical Center ( Site 0035)

    RECRUITING

    Omaha, Nebraska, 68198, United States

  • University of Alabama - Birmingham ( Site 0058)

    RECRUITING

    Birmingham, Alabama, 35233, United States

  • University of Cincinnati Medical Center ( Site 0042)

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • University of Tennessee Medical Center ( Site 0087)

    RECRUITING

    Knoxville, Tennessee, 37920, United States

  • Uniwersytecki Szpital Kliniczny nr2 PUM w Szczecinie ( Site 2103)

    RECRUITING

    Szczecin, West Pomeranian Voivodeship, 70-111, Poland

  • Uniwersytecki Szpital Kliniczny w Poznaniu-Oddzial Ginekologii Onkologicznej ( Site 2106)

    RECRUITING

    Poznan, Greater Poland Voivodeship, 60-569, Poland

  • Virginia Cancer Specialists (VCS) ( Site 8012)

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Virginia Oncology Associates (VOA) ( Site 8013)

    RECRUITING

    Norfolk, Virginia, 23502, United States

  • Vseobecna fakultni nemocnice v Praze ( Site 3305)

    RECRUITING

    Prague, 128 08, Czechia

  • West Cancer Center and Research Institute ( Site 0013)

    RECRUITING

    Germantown, Tennessee, 38138, United States

  • Westmead Hospital ( Site 0201)

    RECRUITING

    Westmead, New South Wales, 2145, Australia

  • Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie ( Site 2105)

    RECRUITING

    Poznan, Greater Poland Voivodeship, 61-866, Poland

  • Winship Cancer Institute of Emory University ( Site 0037)

    RECRUITING

    Atlanta, Georgia, 30308, United States

  • Women & Infants Hospital ( Site 0001)

    RECRUITING

    Providence, Rhode Island, 02905, United States

  • Women's Cancer Care ( Site 0018)

    RECRUITING

    Covington, Louisiana, 70433, United States

  • Womens Cancer Care Associates, LLC ( Site 0023)

    RECRUITING

    Albany, New York, 12208-1743, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.